HS-10587
/ Jiangsu Hansoh Pharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
March 23, 2026
Hansoh Pharmaceutical Group…is pleased to announce that, HS-10587 tablets…has obtained the Clinical Trial Approval issued by the National Medical Products Administration (NMPA) of China, which is intended to be investigated in clinical trials for MTAP- deleted advanced solid tumors
(HKEXnews)
New trial • Solid Tumor
1 to 1
Of
1
Go to page
1